Oncology 2012

Research

American Association of Cancer Research AACR Annual Meeting 2012, April 2012, Chicago, United States of America

• 3795 / BubR1 function is required for the antiproliferative activity of the novel microtubule-targeting drug BAL27862 (active moiety of the prodrug BAL101553). Lane H, Burger K, Bachmann F, Tzankov A, Boutros M, Gilbert D.